Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer Patients
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Pegylated liposomal doxorubicin|DRUG: Cyclophosphamide|DRUG: Epirubicin|DRUG: Docetaxel
Sponsor: Zhejiang University
Collaborators: Second Affiliated Hospital, School of Medicine, Zhejiang University|First Affiliated Hospital of Zhejiang University|Sir Run Run Shaw Hospital|Women's Hospital School Of Medicine Zhejiang University|Zhejiang Cancer Hospital|Zhejiang Provincial People's Hospital|Zhejiang Provincial Hospital of TCM|First People's Hospital of Hangzhou|Hangzhou Hospital of Traditional Chinese Medicine|First Affiliated Hospital of Wenzhou Medical University|Ningbo No. 1 Hospital|Jinhua Central Hospital